Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
340.6 USD | +0.01% | +1.50% | +13.73% |
May. 29 | First European Announces That Surgeries Completed Using Stryker?s Gamma4 Hip Fracture Nailing System | CI |
May. 23 | Stryker Insider Sold Shares Worth $668,308, According to a Recent SEC Filing | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With an expected P/E ratio at 33.32 and 29.06 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.73% | 130B | A- | ||
-8.17% | 10.99B | A- | ||
-4.33% | 8.35B | C | ||
+41.80% | 5.67B | B+ | ||
-21.94% | 4.72B | C | ||
+7.81% | 3.42B | C- | ||
-10.26% | 2.76B | B- | ||
-10.29% | 2.11B | - | - | |
-13.58% | 1.92B | - | ||
-27.77% | 1.68B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SYK Stock
- Ratings Stryker Corporation